Related Experiment Videos
Teratogenic and developmental effects of lithium
James J Giles1, John G Bannigan
1Department of Human Anatomy and Physiology and Conway Institute of Biomolecular and Biomedical Research, National University of Ireland, Dublin, Ireland. seamus.giles@ucd.ie
Current Pharmaceutical Design
|April 14, 2006
Summary
Lithium in pregnancy is a weak teratogen, potentially causing cardiac malformations and higher birth weight in infants. Further research is needed to confirm associations like Ebstein anomaly.
Area of Science:
- Reproductive Toxicology
- Developmental Biology
- Pharmacology
Background:
- Lithium is widely used for bipolar disorder treatment.
- Understanding its effects during human pregnancy is crucial for patient care.
- Existing data on lithium's teratogenicity is varied.
Purpose of the Study:
- To review the effects of therapeutic lithium doses on human pregnancy outcomes.
- To synthesize evidence regarding lithium's teratogenic potential.
- To explore the mechanisms underlying lithium's developmental effects.
Main Methods:
- Comprehensive review of existing literature.
- Inclusion of cohort, prospective, retrospective studies, and case reports.
- Analysis of animal studies at various lithium dosages.
Main Results:
- Lithium is considered a weak human teratogen.
- Associated risks include cardiac malformations and increased infant birth weight.
- Evidence for Ebstein anomaly association remains inconclusive.
- Animal studies show dose-dependent teratogenic effects, including craniofacial and skeletal defects.
Conclusions:
- Lithium poses potential risks during pregnancy, primarily cardiac malformations and altered birth weight.
- Further investigation is warranted to clarify the lithium-Ebstein anomaly link.
- Mechanisms involve interference with the phosphatidyl inositol cycle and GSK-3beta inhibition.